SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Vertex Pharmaceuticals (VRTX) -- Ignore unavailable to you. Want to Upgrade?

To: Miljenko Zuanic who wrote (535)9/24/2001 9:31:56 PM
From: Spekulatius  Read Replies (1) | Respond to of 1169
 
I have a full position in VRTX so you guys have company <ng>
I still wonder why the animal tests have not been done before they went into the clinic - is this an indication of sloppyness? I am specifically concerned that if Timocad bombs as well, VRTX could be in the penalty box for a long time. On the other hand, VRTX looks very cheap with 700M$ in working cap, ABSC and the 900M$ NVS deal.



To: Miljenko Zuanic who wrote (535)9/25/2001 1:58:35 AM
From: Vector1  Read Replies (1) | Respond to of 1169
 
MZ, it probably will not make you feel better but you have lots of company. I think the stock will continue to fall and create a buying opp. Can you believe a number of analysts have called this a minor positive because the efficacy is proof of prinicple.

V1


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News